Fig. 7: Kaplan–Meier survival at 1-year follow-up in the FRISC II trial. Routine invasive management (coronary angiography and revascularization) resulted in lower rates of death than did routine conservative management. [Reprinted, with permission, from Wallentin L et al.³⁰ © 2000 The Lancet Ltd.